| Ms Panaporn Ann Aphivantrakul, CAA | |
|
80 Jesse Hill Jr Dr Se, Atlanta, GA 30303-3050 | |
| (404) 616-1000 | |
| Not Available |
| Full Name | Ms Panaporn Ann Aphivantrakul |
|---|---|
| Gender | Female |
| Speciality | Anesthesiology Assistant |
| Experience | 4 Years |
| Location | 80 Jesse Hill Jr Dr Se, Atlanta, Georgia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083224992 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367H00000X | Anesthesiologist Assistant | 9937 (Georgia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Piedmont Henry Hospital | Stockbridge, GA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Piedmont Anesthesia Llc | 2163837972 | 155 |
News Archive
CASI Pharmaceuticals, Inc., a biopharmaceutical company dedicated to the acquisition, development and commercialization of innovative therapeutics addressing cancer and other unmet medical needs for the global market with a commercial focus on China, announced today that it has filed an application with China's Food and Drug Administration to conduct a Phase 2 clinical trial in fibrolamellar carcinoma (FLC) patients in China for its proprietary drug candidate, ENMD-2076.
Assurances from the Australian Medical Association (AMA) that cancer patients at the Royal Adelaide Hospital are at a minimal risk from an inadvertent 5 per cent reduction in their prescribed radiation dosage between 2004 to 2006, may reassure some but many former patients will still be worried.
Multiple-ligament knee injuries resulting from traumatic knee dislocations - such as high impact car accidents or certain sports are uncommon, and the optimal timing of surgical repair or reconstruction has not been definitively established.
Though hospitals are making strides in avoiding central line-associated blood stream infections (CLABSIs) and catheter-associated urinary tract infections (CAUTIs), a report released today, in the midst of Patient Safety Awareness Week (March 13-19), shows patients are still experiencing these serious, and sometimes fatal, infections too frequently.
Epic Sciences announced today that the company will present single cell sequencing data, from metastatic castrate resistant prostate cancer patients, at the 2015 annual meeting of the American Society for Clinical Oncology. This application expands the investigational utility of Epic Sciences' no cell left behind™ platform to characterize circulating tumor cell (CTC) genomic alterations.
› Verified 6 days ago
| Entity Name | American Anesthesiology Associates Of Georgia Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528068673 PECOS PAC ID: 7618934779 Enrollment ID: O20041210000442 |
News Archive
CASI Pharmaceuticals, Inc., a biopharmaceutical company dedicated to the acquisition, development and commercialization of innovative therapeutics addressing cancer and other unmet medical needs for the global market with a commercial focus on China, announced today that it has filed an application with China's Food and Drug Administration to conduct a Phase 2 clinical trial in fibrolamellar carcinoma (FLC) patients in China for its proprietary drug candidate, ENMD-2076.
Assurances from the Australian Medical Association (AMA) that cancer patients at the Royal Adelaide Hospital are at a minimal risk from an inadvertent 5 per cent reduction in their prescribed radiation dosage between 2004 to 2006, may reassure some but many former patients will still be worried.
Multiple-ligament knee injuries resulting from traumatic knee dislocations - such as high impact car accidents or certain sports are uncommon, and the optimal timing of surgical repair or reconstruction has not been definitively established.
Though hospitals are making strides in avoiding central line-associated blood stream infections (CLABSIs) and catheter-associated urinary tract infections (CAUTIs), a report released today, in the midst of Patient Safety Awareness Week (March 13-19), shows patients are still experiencing these serious, and sometimes fatal, infections too frequently.
Epic Sciences announced today that the company will present single cell sequencing data, from metastatic castrate resistant prostate cancer patients, at the 2015 annual meeting of the American Society for Clinical Oncology. This application expands the investigational utility of Epic Sciences' no cell left behind™ platform to characterize circulating tumor cell (CTC) genomic alterations.
› Verified 6 days ago
| Entity Name | Grady Memorial Hospital Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114243813 PECOS PAC ID: 7517032998 Enrollment ID: O20100723000311 |
News Archive
CASI Pharmaceuticals, Inc., a biopharmaceutical company dedicated to the acquisition, development and commercialization of innovative therapeutics addressing cancer and other unmet medical needs for the global market with a commercial focus on China, announced today that it has filed an application with China's Food and Drug Administration to conduct a Phase 2 clinical trial in fibrolamellar carcinoma (FLC) patients in China for its proprietary drug candidate, ENMD-2076.
Assurances from the Australian Medical Association (AMA) that cancer patients at the Royal Adelaide Hospital are at a minimal risk from an inadvertent 5 per cent reduction in their prescribed radiation dosage between 2004 to 2006, may reassure some but many former patients will still be worried.
Multiple-ligament knee injuries resulting from traumatic knee dislocations - such as high impact car accidents or certain sports are uncommon, and the optimal timing of surgical repair or reconstruction has not been definitively established.
Though hospitals are making strides in avoiding central line-associated blood stream infections (CLABSIs) and catheter-associated urinary tract infections (CAUTIs), a report released today, in the midst of Patient Safety Awareness Week (March 13-19), shows patients are still experiencing these serious, and sometimes fatal, infections too frequently.
Epic Sciences announced today that the company will present single cell sequencing data, from metastatic castrate resistant prostate cancer patients, at the 2015 annual meeting of the American Society for Clinical Oncology. This application expands the investigational utility of Epic Sciences' no cell left behind™ platform to characterize circulating tumor cell (CTC) genomic alterations.
› Verified 6 days ago
| Entity Name | Piedmont Anesthesia Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700474244 PECOS PAC ID: 2163837972 Enrollment ID: O20210208002823 |
News Archive
CASI Pharmaceuticals, Inc., a biopharmaceutical company dedicated to the acquisition, development and commercialization of innovative therapeutics addressing cancer and other unmet medical needs for the global market with a commercial focus on China, announced today that it has filed an application with China's Food and Drug Administration to conduct a Phase 2 clinical trial in fibrolamellar carcinoma (FLC) patients in China for its proprietary drug candidate, ENMD-2076.
Assurances from the Australian Medical Association (AMA) that cancer patients at the Royal Adelaide Hospital are at a minimal risk from an inadvertent 5 per cent reduction in their prescribed radiation dosage between 2004 to 2006, may reassure some but many former patients will still be worried.
Multiple-ligament knee injuries resulting from traumatic knee dislocations - such as high impact car accidents or certain sports are uncommon, and the optimal timing of surgical repair or reconstruction has not been definitively established.
Though hospitals are making strides in avoiding central line-associated blood stream infections (CLABSIs) and catheter-associated urinary tract infections (CAUTIs), a report released today, in the midst of Patient Safety Awareness Week (March 13-19), shows patients are still experiencing these serious, and sometimes fatal, infections too frequently.
Epic Sciences announced today that the company will present single cell sequencing data, from metastatic castrate resistant prostate cancer patients, at the 2015 annual meeting of the American Society for Clinical Oncology. This application expands the investigational utility of Epic Sciences' no cell left behind™ platform to characterize circulating tumor cell (CTC) genomic alterations.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ms Panaporn Ann Aphivantrakul, CAA 80 Jesse Hill Jr Dr Se, Atlanta, GA 30303-3031 Ph: (404) 616-1000 | Ms Panaporn Ann Aphivantrakul, CAA 80 Jesse Hill Jr Dr Se, Atlanta, GA 30303-3050 Ph: (404) 616-1000 |
News Archive
CASI Pharmaceuticals, Inc., a biopharmaceutical company dedicated to the acquisition, development and commercialization of innovative therapeutics addressing cancer and other unmet medical needs for the global market with a commercial focus on China, announced today that it has filed an application with China's Food and Drug Administration to conduct a Phase 2 clinical trial in fibrolamellar carcinoma (FLC) patients in China for its proprietary drug candidate, ENMD-2076.
Assurances from the Australian Medical Association (AMA) that cancer patients at the Royal Adelaide Hospital are at a minimal risk from an inadvertent 5 per cent reduction in their prescribed radiation dosage between 2004 to 2006, may reassure some but many former patients will still be worried.
Multiple-ligament knee injuries resulting from traumatic knee dislocations - such as high impact car accidents or certain sports are uncommon, and the optimal timing of surgical repair or reconstruction has not been definitively established.
Though hospitals are making strides in avoiding central line-associated blood stream infections (CLABSIs) and catheter-associated urinary tract infections (CAUTIs), a report released today, in the midst of Patient Safety Awareness Week (March 13-19), shows patients are still experiencing these serious, and sometimes fatal, infections too frequently.
Epic Sciences announced today that the company will present single cell sequencing data, from metastatic castrate resistant prostate cancer patients, at the 2015 annual meeting of the American Society for Clinical Oncology. This application expands the investigational utility of Epic Sciences' no cell left behind™ platform to characterize circulating tumor cell (CTC) genomic alterations.
› Verified 6 days ago
Matthew Lewis, PAA Anesthesiologist Assistant Medicare: Medicare Enrolled Practice Location: 1405 Clifton Rd Ne Fl 3, Atlanta, GA 30322 Phone: 404-785-6670 Fax: 404-785-1362 | |
Elizabeth Ikeda, Anesthesiologist Assistant Medicare: Medicare Enrolled Practice Location: 1365 Clifton Rd Ne, Atlanta, GA 30322 Phone: 404-778-8311 | |
Amar R Herndon, Anesthesiologist Assistant Medicare: Medicare Enrolled Practice Location: 1000 Johnson Ferry Rd Ne, Atlanta, GA 30342 Phone: 770-645-9181 | |
Shelley S Staton, PAAA Anesthesiologist Assistant Medicare: Medicare Enrolled Practice Location: 1000 Johnson Ferry Rd, Atlanta, GA 30342 Phone: 770-645-9181 Fax: 770-645-8455 | |
Mr. Grant Michael Mury, PAA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 550 Peachtree St Ne, Atlanta, GA 30308 Phone: 404-778-3900 | |
Ashley Schade, PAAA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 5665 Peachtree Dunwoody Rd, Atlanta, GA 30342 Phone: 706-543-3449 | |
Jiaqi Tracy Li, PAA Anesthesiologist Assistant Medicare: Medicare Enrolled Practice Location: 1001 Johnson Fy Rd Ne, Atlanta, GA 30342 Phone: 404-785-2008 Fax: 404-785-4496 |